Astorg and Nordic Capital-backed Clario completed the acquisition of an electronic clinical outcome assessment business from WCG.

Astorg and Nordic Capital-backed Clario, a provider of endpoint technology solutions for clinical trials, completed the acquisition of an electronic clinical outcome assessment (eCOA) business, from WCG, a clinical research solutions provider. Financial terms were not disclosed. "I am excited to bring WCG’s eCOA team and technologies to Clario. Our clients now have access to the most reliable, high-quality data across multiple modalities and all major neuroscience endpoints. This will have wide-ranging benefits for our customers and to patients in this area of significant unmet medical need," Chris Fikry, Clario CEO.